Siemens, Nears

Siemens Nears Record High as SBB Contract Adds Long-Term Revenue Visibility

Published on 07/30/2026 at 16:52 | Redaktion boerse-global.de

Siemens shares rally 4% in seven sessions, fueled by a €280M Swiss rail deal and upbeat guidance. Analysts raise price targets ahead of Q3 earnings and Healthineers demerger.

Siemens Stock Nears Record High on Rail Contracts and Healthineers Split
Siemens Nears Record High as SBB Contract Adds Long-Term Revenue Visibility Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

Siemens shares have been on a tear, climbing 2.88 percent to €278.80 and bringing the stock within 2.09 percent of its July 2026 record high of €284.75. The seven-session rally of 4.05 percent has more than erased a prior soft patch that left the 30-day performance at minus 0.61 percent. With a relative strength index of 57.9, the stock is not yet overbought, leaving technical room for further gains.

The recent upward momentum has been fueled by a combination of operational upgrades and a steady stream of large-scale rail contracts. On Wednesday, Swiss Federal Railways (SBB) disclosed a contract extension worth up to 280 million Swiss francs for the continued operation of the Iltis rail control system — a mandate awarded without competitive bidding because Siemens holds the proprietary rights and the technical expertise to maintain the system. The contract, published on the Simap procurement platform, covers technical support until the planned replacement of Iltis, which is not expected before 2045.

The SBB deal is the latest in a series of wins for Siemens Mobility in Switzerland. It follows a recent multibillion-euro order for double-decker trains for the Zurich S-Bahn and a 2013 contract worth roughly 325 million francs to upgrade Iltis and rebuild the traffic control systems at four operational centers. The new agreement ensures a long-term, competition-free revenue stream from the Swiss rail market, with all work performed at the company's Wallisellen site.

Two Catalysts on the Horizon

Investors are now focused on two events that will shape the stock's trajectory over the coming months: the next quarterly earnings report and the planned separation of Siemens Healthineers. The demerger requires a shareholder vote at the annual general meeting in February 2027, and while the separation process is advanced, regulatory clearance has not yet been finalized. CEO Roland Busch has indicated that deconsolidation may not be completed until next year, leaving room for potential delays or regulatory hurdles.

Should investors sell immediately? Or is it worth buying Siemens?

The quarterly report, due in the third calendar quarter of 2026, will be the critical test. The market has already priced in a significant vote of confidence following the company's upward revisions to its full-year guidance for Digital Industries and Smart Infrastructure. Digital Industries now expects revenue growth of 7 to 10 percent with a margin between 17 and 19 percent, while Smart Infrastructure's growth outlook was raised to 8 to 10 percent with margins holding at 18 to 19 percent.

Analysts have responded positively. JPMorgan's Phil Buller lifted his price target from €335 to €345, anticipating a continuation of the positive trend. UBS followed with an increase from €300 to €310, maintaining a buy recommendation. A €6 billion share buyback program launched on July 1 and running through 2031 provides additional structural support for the stock, gradually boosting earnings per share.

Not All Signals Are Green

Despite the bullish momentum, cautionary notes persist. Deutsche Bank Research raised its price target from €255 to €260 but kept a "Hold" rating, suggesting that much of the optimism is already reflected in the price. The Mobility division, which delivered the SBB contract, has itself seen a downward revision in growth expectations — now 5 to 7 percent, down from the prior 8 to 10 percent — highlighting uneven performance across the conglomerate's portfolio.

Siemens at a turning point? This analysis reveals what investors need to know now.

The stock's annualized volatility of 27.59 percent and a 12-month gain of 21.77 percent make larger swings in either direction more likely. If the next quarterly report confirms the upgraded segment targets, a push past the record high and beyond is plausible. Should the numbers disappoint or Healthineers-related uncertainty resurface, the 100-day moving average at €254.40 and the 200-day moving average at €248.08 would serve as the next support levels.

For now, Siemens remains above its 50-day moving average of €271.57, and the SBB contract adds a layer of dependable, long-duration revenue that complements the cyclical growth story. The stock closed Wednesday at €271.00, down 0.35 percent on the day, but up 13.37 percent year-to-date — a performance that keeps the record high firmly within striking distance.

Ad

Siemens Stock: New Analysis - 30 July

Fresh Siemens information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Siemens analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE0007236101 | SIEMENS | boerse | 69901010 |